Scarica l'app Stockscreener
90.46
0.07%
0.06
Pre-mercato:
89.87
-0.59
-0.65%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVTY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$90.40
Aprire:
$89.58
Volume 24 ore:
1.10M
Relative Volume:
0.84
Capitalizzazione di mercato:
$10.11B
Reddito:
$2.86B
Utile/perdita netta:
$239.88M
Rapporto P/E:
43.28
EPS:
2.0903
Flusso di cassa netto:
$506.94M
1 W Prestazione:
+1.71%
1M Prestazione:
-1.79%
6M Prestazione:
-1.31%
1 anno Prestazione:
-10.74%
Intervallo 1D:
$87.23
$90.91
Intervallo di 1 settimana:
$86.23
$92.99
Portata 52W:
$81.36
$118.30
Revvity Inc Stock (RVTY) Company Profile
Nome
Revvity Inc
Settore
Industria
Telefono
781-663-6900
Indirizzo
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
90.46 | 10.11B | 2.86B | 239.88M | 506.94M | 2.0903 |
TMO
Thermo Fisher Scientific Inc
|
500.46 | 187.10B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
192.99 | 138.84B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
584.75 | 47.01B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.39 | 33.04B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
317.65 | 31.25B | 3.17B | 642.63M | 516.49M | 10.77 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-12-09 | Iniziato | Goldman | Neutral |
| 2025-10-16 | Iniziato | Guggenheim | Neutral |
| 2025-05-01 | Aggiornamento | UBS | Neutral → Buy |
| 2025-01-10 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-07-08 | Iniziato | Leerink Partners | Outperform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | UBS | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-23 | Ripresa | Goldman | Buy |
Mostra tutto
Revvity Inc Borsa (RVTY) Ultime notizie
Revvity (RVTY) Introduces New Cloud-Based Molecular Cloning Plat - GuruFocus
Revvity launches cloud-based molecular cloning software platform By Investing.com - Investing.com South Africa
Revvity (RVTY) Launches Cloud-Based Molecular Cloning Solution - GuruFocus
Revvity Launches Signals BioDesign Offering for Biologics Research Workflows - marketscreener.com
Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows - Yahoo Finance
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Swing Trade: Can Revvity Inc outperform in the next rallyLayoff News & Expert-Curated Trade Recommendations - baoquankhu1.vn
Revvity Sees Growth in Diagnostics, Encounters Challenges in China - Bitget
Revvity Gains on Diagnostics Strength, Faces China Headwinds - TradingView
Evercore ISI Adjusts Revvity Price Target to $108 From $118, Maintains Outperform Rating - marketscreener.com
Evercore Maintains Revvity(RVTY.US) With Buy Rating, Cuts Target Price to $108 - Moomoo
Tudor Investment Corp ET AL Purchases Shares of 172,601 Revvity Inc. $RVTY - MarketBeat
Revvity (RVTY) Valuation Check After Recent Share Price Momentum Shift - Yahoo Finance
Revvity, Inc. (RVTY) Stock Price, News, Quote & History - Yahoo! Finance Canada
META_TITLE_QUOTE - Yahoo Finance Singapore
Revvity at TD Cowen: Strategic Growth and Margin Expansion - Investing.com
Revvity, Inc. (RVTY) stock price, news, quote and history - Yahoo Finance UK
Baird Maintains Revvity (RVTY) Outperform Recommendation - MSN
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
Here’s Artisan Mid Cap Value Fund’s Investment Thesis for Revvity (RVTY) - Yahoo Finance
Revvity Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Liquidity Mapping Around (RVTY) Price Events - Stock Traders Daily
Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’ - MSN
JP Morgan Lowers Revvity (RVTY) Price Target to $96, Maintains N - GuruFocus
Revvity (NYSE:RVTY) Price Target Cut to $96.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
J.P. Morgan Initiates Revvity(RVTY.US) With Hold Rating, Announces Target Price $96 - Moomoo
JPMorgan Adjusts Price Target on Revvity to $96 From $105, Maintains Neutral Rating - marketscreener.com
Allspring Global Investments Holdings LLC Raises Holdings in Revvity Inc. $RVTY - MarketBeat
RVTY Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Revvity Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Revvity Inc (RVTY) Shares Gap Down to $83.9 on Mar 30 - GuruFocus
Stifel maintains a hold rating on Revvity (RVTY) - MSN
Revvity Vote On Special Meetings And Stock Retention Meets Valuation Gap - Sahm
SG Americas Securities LLC Boosts Stock Holdings in Revvity Inc. $RVTY - MarketBeat
Revvity stock price forecast: persistent downtrend and oversold signals as RVTY nears 52-week low - Traders Union
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
Vanguard disaggregates holdings; Revvity (RVTY) filing shows 0 shares - Stock Titan
Stifel Maintains a Hold Rating on Revvity (RVTY) - Insider Monkey
Revvity Inc. Stock: Navigating Life Sciences Headwinds and Q4 Earnings Pressure Ahead - AD HOC NEWS
Here's why you should retain Revvity stock in your portfolio for now - MSN
Revvity Inc. stock faces pressure amid life sciences sector slowdown as Q4 earnings loom - AD HOC NEWS
EdgePoint Investment Group Inc.'s Revvity Inc(RVTY) Holding History - GuruFocus
10 Best Mid Cap Value Stocks to Buy in 2026 - Insider Monkey
Research Alert: CFRA Maintains Buy Rating On Shares Of Revvity, Inc. - Moomoo
Revvity Inc. stock faces pressure amid life sciences sector slowdown and looming Q4 earnings test - AD HOC NEWS
Is Revvity stock underperforming the S&P 500? - MSN
Revvity Inc. stock faces pressure amid life sciences sector slowdown and acquisition integration cha - AD HOC NEWS
Bull Bear: Can Revvity Inc outperform in the next rally2026 Weekly Recap & Weekly Watchlist of Top Performers - baoquankhu1.vn
Why is Revvity (RVTY) down 5.1% since last earnings report? - MSN
Revvity, Inc. (RVTY) Stock forecasts - Yahoo Finance UK
Is Revvity Inc a play on infrastructure spendingMarket Performance Recap & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Revvity Inc Azioni (RVTY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.50%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):